Last close As at 06/08/2026
—
— 0.00 (0.00%)
Market capitalisation
—
Research: Metals & Mining
Endeavour’s premium listing on the LSE brings the largest producer of gold in the second largest gold producing region to London to pick up the mantle vacated by Randgold when it departed these shores in 2018. Like Randgold, Endeavour has set a 20% post-tax IRR hurdle rate from its investments (at a gold price of US$1,300/oz), is targeting a 20% return on capital employed, an AISC of US$900/oz and has recently announced a progressive dividend policy and share buyback programme.
Endeavour Mining |
Picking up the crown |
Premium LSE listing |
Metals & mining |
14 June 2021 |
Share price performance
Business description
Next events
Analyst
Endeavour Mining is a research client of Edison Investment Research Limited |
||||||||||||||||||||||||||||||||||||||||||||||||||||
Endeavour’s premium listing on the LSE brings the largest producer of gold in the second largest gold producing region to London to pick up the mantle vacated by Randgold when it departed these shores in 2018. Like Randgold, Endeavour has set a 20% post-tax IRR hurdle rate from its investments (at a gold price of US$1,300/oz), is targeting a 20% return on capital employed, an AISC of US$900/oz and has recently announced a progressive dividend policy and share buyback programme.
Year end |
Revenue (US$m) |
EBITDA (US$m) |
PBT* |
Op. cash flow |
DPS |
Yield |
12/19 |
1,362.1 |
618.4 |
220.4 |
3.30 |
0 |
N/A |
12/20 |
1,847.9 |
910.3 |
501.2 |
5.35 |
37 |
1.5 |
12/21e |
2,758.1 |
1,386.6 |
788.1 |
3.68 |
50 |
2.1 |
12/22e |
2,495.1 |
1,417.3 |
930.2 |
4.82 |
60 |
2.5 |
Note: Pro forma basis. *PBT is normalised, excluding amortisation of acquired intangibles and exceptional items.
In the right place at the right time…
West Africa remains under-explored, despite accounting for the largest number of gold ounces discovered in any region in the past decade. According to some forecasts, it will surpass China in terms of output within a few years. It also offers simple geology, simple terrain, good infrastructure and good jurisdictional risk, where governments have made concerted efforts to ensure the region is attractive to gold mining companies, without being over-dependent on a single industry.
…with the right track record
In the past 10 years Endeavour has invested more than US$1bn to build four mines with zero lost time. In the meantime, it has adopted an exploration approach that is drawn from the oil & gas, rather than mining, industry and has been successful in delineating 84% of its five-year target of 10–15m resource ounces after only four years to increase medium-term production levels at Ity and Houndé to 0.5Moz pa (combined) until at least 2028.
Valuation: US$35.88 or C$43.45 or £25.42 per share
Having changed nothing but our dividend assumptions and updated our estimate of shares in issue to reflect the latest buyback data, our valuation of Endeavour remains substantially unchanged relative to our last note (Showing its mettle as well as its metal, published on 28 May 2021). Based on the average multiples of its gold major peers, we estimate a valuation for Endeavour of US$37.02 (C$44.82 or £26.23) per share. By contrast, using an absolute valuation methodology, whereby we discount back six years of cash flow and then apply an ex-growth, ad infinitum multiple to steady-state terminal cash flows in FY26, implies a valuation of US$35.88 (C$43.45 or £25.42) per share if a standardised 10% discount rate is used or US$56.96 (C$68.97 or £40.36) per share if a CAPM-derived discount rate of 6.5% is used. In the meantime, it is trading at a discount to the average multiples of its LSE peers in at least two-thirds of common valuation measures (see Exhibit 3) despite being the largest premium LSE-listed pure gold producer.
Valuation summary
Endeavour is a multi-asset company that has shown a willingness and desire to trade assets to maintain production, reduce costs and maximise returns to shareholders (eg the sale of Youga in FY16, Nzema in FY17, Tabakoto in FY18 and Agbaou in FY20 and the acquisition of SEMAFO in FY20 and Teranga in FY21). Historically, rather than our customary method of discounting maximum potential dividends over the life of operations back to FY21, in the case of Endeavour, we have instead opted to discount six years of forecast cash flows in FY21–26 back to the start of FY21 and then to apply an ex-growth terminal multiple of 10x (consistent with using a standardised discount rate of 10%) to forecast cash flows in that year (ie FY26). In the normal course of events, exploration expenditure would be excluded from such a calculation on the basis that it is an investment. In the case of Endeavour, however, it has been included on the grounds that it is a critical component of its ongoing business performance to enable it to continually expand and extend the lives of its mines.
In this case, our estimate of cash flows in FY26 is US$4.03 (cf US$4.00/share previously), giving rise to a terminal valuation of the company at end-FY26 of US$40.30/share (cf US$39.96/share previously), which (in conjunction with forecast intervening cash flows) then discounts back to a valuation of US$35.88/share (cf US$35.66/share previously) at the start of FY21, as shown in the graph below.
|
Exhibit 1: Endeavour current forecast valuation and cash flow per share, FY21–26e (US$/share) |
|
|
Source: Edison Investment Research |
Given its elevation into the ranks of the world’s foremost producers of gold however, we believe that Endeavour can increasingly attract lower cost finance and, as such, a capital asset pricing model (CAPM)-derived WACC can also be considered (as discussed in our February 2021 initiation on Newmont Corporation). Long-term nominal equity returns have been 9% and 30-year break-evens are expecting 2.32% inflation. These two measures imply an expected real equity return of 6.5% (1.09/1.0232) and applying this to our forecast cash flows would imply a terminal valuation for Endeavour of US$61.76/share (cf US$60.05/share previously) and a current valuation of US$56.96/share (cf US$55.39/share previously). Readers should note that, given its realised beta of 0.56 (source: Refinitiv, 10 June 2021), even this (real) discount rate of 6.5% is likely to prove conservative.
In the meantime, Endeavour’s valuation remains at a material discount to those of its newly acquired peer group of gold majors, as shown in Exhibit 2, below.
Relative Endeavour valuation
Endeavour’s valuation on a series of commonly used measures, relative to a selection of gold mining majors (the ranks of which it has now joined following its takeovers of SEMAFO and Teranga), is as follows:
Exhibit 2: Endeavour valuation relative to global gold major peers
Company |
Ticker |
Price/cash flow (x) |
EV/EBITDA (x) |
Yield (%) |
||||||
Year 1 |
Year 2 |
Year 3 |
Year 1 |
Year 2 |
Year 3 |
Year 1 |
Year 2 |
Year 3 |
||
Endeavour (Edison) |
EDV |
6.5 |
5.0 |
4.9 |
4.6 |
*4.2 |
*3.3 |
2.1 |
2.5 |
3.0 |
Endeavour (consensus) |
EDV |
4.9 |
4.5 |
5.0 |
4.6 |
4.4 |
4.9 |
1.9 |
3.8 |
3.8 |
Majors |
||||||||||
Barrick |
ABX |
7.8 |
7.7 |
7.9 |
7.2 |
6.8 |
6.9 |
2.6 |
1.5 |
1.8 |
Newmont |
NEM |
10.6 |
9.7 |
11.2 |
8.3 |
7.8 |
8.9 |
2.9 |
3.0 |
2.8 |
Newcrest |
NCM AU |
9.0 |
9.0 |
9.3 |
7.6 |
7.5 |
7.7 |
1.5 |
1.5 |
1.7 |
Kinross |
K |
6.2 |
4.5 |
4.6 |
5.4 |
4.0 |
3.9 |
1.6 |
1.6 |
1.6 |
Agnico-Eagle |
AEM |
10.6 |
9.7 |
9.9 |
9.5 |
8.1 |
8.5 |
2.1 |
2.1 |
2.0 |
Eldorado |
ELD |
5.7 |
5.0 |
4.9 |
4.7 |
4.2 |
4.1 |
0.0 |
0.0 |
0.0 |
Average |
|
8.3 |
7.6 |
7.9 |
7.1 |
6.4 |
6.7 |
1.8 |
1.6 |
1.6 |
Implied EDV share price (US$) |
30.60 |
36.76 |
37.96 |
39.43 |
39.16 |
41.41 |
27.93 |
37.31 |
42.64 |
|
Implied EDV share price (C$) |
36.98 |
44.51 |
45.97 |
47.75 |
47.41 |
50.15 |
33.82 |
45.17 |
51.63 |
|
Source: Edison Investment Research, Refinitiv. Note: *Forecast EV. Consensus and peers priced at 10 June 2021.
Of note is the fact that Endeavour’s valuation is materially cheaper than the averages of the majors in all the measures shown in Exhibit 2, regardless of whether consensus or Edison forecasts are used. On an individual basis, it is cheaper than the majors on at least 45 out of 54 (83%) of individual valuation measures if Edison forecasts are used or 45 out of 54 (83%) if consensus forecasts are used. Reverse engineered, the average valuation measures of its peers imply an average share price for Endeavour of US$37.02, or C$44.82 or £26.23, per share.
Relative to its new-found peers listed in London, Endeavour’s valuation is as follows:
Exhibit 3: Endeavour valuation relative to London-listed precious metal peers
Company |
Ticker |
Price/cash flow (x) |
EV/EBITDA (x) |
Yield (%) |
||||||
Year 1 |
Year 2 |
Year 3 |
Year 1 |
Year 2 |
Year 3 |
Year 1 |
Year 2 |
Year 3 |
||
Endeavour (Edison) |
EDV |
6.5 |
5.0 |
4.9 |
4.6 |
*4.2 |
*3.3 |
2.1 |
2.5 |
3.0 |
Endeavour (consensus) |
EDV |
4.9 |
4.5 |
5.0 |
4.6 |
4.4 |
4.9 |
1.9 |
3.8 |
3.8 |
LSE-listed peers |
||||||||||
Polymetal |
POLYP |
8.1 |
6.9 |
8.1 |
7.3 |
6.6 |
7.4 |
6.5 |
7.9 |
6.5 |
Fresnillo |
FRES |
9.1 |
8.4 |
9.3 |
6.6 |
5.4 |
6.0 |
2.9 |
3.4 |
3.0 |
Centamin |
CEY |
11.2 |
9.3 |
4.4 |
4.3 |
3.9 |
4.2 |
5.9 |
4.4 |
3.4 |
Petropavlovsk |
POG |
7.2 |
4.5 |
4.3 |
5.8 |
4.2 |
4.2 |
0.0 |
3.4 |
5.5 |
Hochschild |
HOC |
4.7 |
4.7 |
5.8 |
3.2 |
3.3 |
3.7 |
2.0 |
2.0 |
2.2 |
Polyus |
PLZL |
9.1 |
8.0 |
8.0 |
7.7 |
7.6 |
7.4 |
3.7 |
4.3 |
4.4 |
Yamana Gold |
YRI |
5.9 |
5.6 |
7.3 |
5.7 |
5.4 |
6.0 |
2.3 |
2.3 |
2.2 |
Resolute Mining |
RSG AU |
2.5 |
2.2 |
2.4 |
3.6 |
2.8 |
3.2 |
3.3 |
3.0 |
3.5 |
Hummingbird |
HUMR |
2.5 |
3.0 |
3.5 |
2.5 |
2.2 |
0.0 |
0.0 |
||
Shanta |
SHAN |
3.1 |
3.3 |
2.7 |
2.2 |
1.8 |
1.3 |
|||
Chaarat |
CGH |
9.5 |
16.0 |
13.9 |
3.8 |
0.0 |
0.0 |
0.0 |
||
Pan African** |
PAFR |
4.8 |
3.7 |
3.3 |
3.8 |
3.3 |
3.1 |
3.9 |
3.4 |
8.6 |
Average |
|
6.8 |
5.6 |
5.9 |
5.9 |
5.2 |
4.5 |
2.7 |
3.0 |
3.7 |
Implied EDV share price (US$) |
24.95 |
27.19 |
28.04 |
32.69 |
32.15 |
29.70 |
18.36 |
20.13 |
18.94 |
|
Implied EDV share price (C$) |
30.21 |
32.92 |
33.95 |
39.58 |
38.93 |
35.96 |
22.24 |
24.37 |
22.94 |
|
Source: Edison Investment Research, Refinitiv. Note: *Forecast EV. **Edison forecasts. Consensus and peers priced at 10 June 2021.
Of note is the fact that Endeavour’s valuation is materially cheaper than the averages of its LSE-listed peers in six out of nine of the measures shown in Exhibit 2 if Edison forecasts are used and seven out of nine if consensus forecasts are used. On an individual basis, it is cheaper than its LSE listed peers on 49 out of 101 (48%) of individual valuation measures if Edison forecasts are used or 53 out of 101 (52%) if consensus forecasts are used. Reverse engineered, the average valuation measures of its LSE-listed peers imply an average share price for Endeavour of US$25.79, C$31.23 or £18.27 per share.
Dividend adjustments
Edison has adjusted its dividend distribution assumptions since Endeavour’s capital markets day (CMD) on 7 June.
Previously (when it declared its maiden dividend of US$0.37/share for FY20 in November), Endeavour announced a policy of declaring future dividends on a semi-annual basis with the aim of maintaining an approximate dividend yield of 1.6% until it reached a targeted net cash position of c US$250m (note, in H122 according to our estimates). Thereupon, it said that it would re-assess its capital allocation priorities, which could involve augmenting its shareholder return programme. As a result, our previous dividend forecast for FY22 and FY23 was based on the maximum distribution that Endeavour could make and still retain a net cash position of US$250m on its balance sheet. Although we believed that such payouts would be unlikely in practice, this methodology nevertheless served to demonstrate the latitude that Endeavour had at its disposal to increase its dividend distributions in the short to medium term.
At its CMD however, Endeavour announced an update to its dividend policy to the effect that it would pay minimum progressive dividends of 50 US cents, 60c and 70c per share in FY21, FY22 and FY23, respectively (assuming that the gold price remains above US$1,500/oz, otherwise payment becomes discretionary based on balance sheet strength), with the potential for additional supplementary shareholder returns as long as net debt remains below 0.5x EBITDA.
Financials
According to its Q121 balance sheet, Endeavour had net debt of US$220.2m post the acquisition of Teranga and the injection of US$200m by La Mancha. This compares with net debt of US$43.3m as at end-FY20 (pre the Teranga acquisition). This figure of US$220.2m includes lease liabilities of US$43.6m and an option premium of US$46.3m. Excluding the latter results in a net debt position of US$173.9m or just 4.3% of the company’s balance sheet equity of US$4,007.7m at end-Q121. Note that it differs slightly from the figure of US$161.8m quoted elsewhere in Endeavour’s announcements in that the latter excludes US$43.6m in lease liabilities and owing to the discounting, variously, of certain committed future payments to present value.
Note that, for the purposes of its financial modelling (see Exhibit 3, below) and for simplicity’s sake, we have assumed the consolidation of Endeavour’s and Teranga’s balance sheets took place retrospectively on 31 December 2020. In this case, we estimate that Endeavour would have consolidated c US$242.6m in net debt on its balance sheet and c US$349.2m in gross debt as a consequence of its Teranga acquisition. As such, on a pro forma basis, we estimate Endeavour would have had US$323.1m in net debt on its balance sheet at end-FY20, which we calculate would have equated to a gearing (net debt/equity) ratio of just 8.8% and a leverage (net debt/[net debt+equity]) ratio of 8.1% on the group’s enlarged equity base.
Exhibit 4: Financial summary
US$'000s |
2018 |
2019 |
2020 |
2021e |
2022e |
2023e |
||
Year end 31 December |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
||
PROFIT & LOSS |
||||||||
Revenue |
|
|
1,048,636 |
1,362,121 |
1,847,894 |
2,758,101 |
2,495,073 |
2,384,441 |
Cost of Sales |
(669,719) |
(884,869) |
(1,061,891) |
(1,383,683) |
(1,077,784) |
(1,034,014) |
||
Gross Profit |
378,917 |
477,252 |
786,003 |
1,374,418 |
1,417,289 |
1,350,427 |
||
EBITDA |
|
|
378,917 |
618,443 |
910,295 |
1,386,578 |
1,417,289 |
1,350,427 |
Operating Profit (before amort. and except.) |
|
106,090 |
281,400 |
546,072 |
836,328 |
930,000 |
920,276 |
|
Intangible Amortisation |
0 |
0 |
0 |
0 |
0 |
0 |
||
Exceptionals |
8,035 |
(199,159) |
(201,532) |
29,917 |
0 |
0 |
||
Other |
(3,171) |
(9,392) |
8,886 |
(19,750) |
0 |
0 |
||
Operating Profit |
110,954 |
72,849 |
353,426 |
846,495 |
930,000 |
920,276 |
||
Net Interest |
(27,110) |
(51,607) |
(53,774) |
(28,502) |
244 |
7,248 |
||
Profit Before Tax (norm) |
|
|
75,809 |
220,401 |
501,184 |
788,076 |
930,245 |
927,524 |
Profit Before Tax (FRS 3) |
|
|
83,844 |
21,242 |
299,652 |
817,993 |
930,245 |
927,524 |
Tax |
(73,637) |
(97,253) |
(158,466) |
(231,736) |
(178,048) |
(168,831) |
||
Profit After Tax (norm) |
2,172 |
123,148 |
342,718 |
556,340 |
752,197 |
758,693 |
||
Profit After Tax (FRS 3) |
10,207 |
(76,011) |
141,186 |
586,257 |
752,197 |
758,693 |
||
Net loss from discontinued operations |
(154,795) |
(4,394) |
0 |
0 |
0 |
0 |
||
Minority interests |
8,460 |
33,126 |
44,719 |
87,964 |
110,447 |
109,000 |
||
Net profit |
(144,588) |
(80,405) |
141,186 |
586,257 |
752,197 |
758,693 |
||
Net attrib. to shareholders contg. businesses (norm) |
(16,292) |
90,022 |
297,998 |
468,376 |
641,750 |
649,694 |
||
Net attrib.to shareholders contg. businesses |
(8,257) |
(109,137) |
96,466 |
498,293 |
641,750 |
649,694 |
||
Average Number of Shares Outstanding (m) |
155.3 |
157.4 |
160.8 |
250.4 |
250.4 |
250.4 |
||
EPS - normalised ($) |
|
|
(0.10) |
0.57 |
1.85 |
1.87 |
2.56 |
2.59 |
EPS - normalised and fully diluted ($) |
|
|
(0.10) |
0.57 |
1.82 |
1.85 |
2.53 |
2.56 |
EPS - (IFRS) ($) |
|
|
(0.99) |
(0.72) |
0.60 |
1.99 |
2.56 |
2.59 |
Dividend per share (c) |
0 |
0 |
37 |
50 |
60 |
70 |
||
Gross Margin (%) |
36.1 |
35.0 |
42.5 |
49.8 |
56.8 |
56.6 |
||
EBITDA Margin (%) |
36.1 |
45.4 |
49.3 |
50.3 |
56.8 |
56.6 |
||
Operating Margin (before GW and except.) (%) |
10.1 |
20.7 |
29.6 |
30.3 |
37.3 |
38.6 |
||
BALANCE SHEET |
||||||||
Fixed Assets |
|
|
1,594,202 |
2,330,033 |
5,093,409 |
5,111,622 |
4,996,160 |
4,918,676 |
Intangible Assets |
4,186 |
5,498 |
24,851 |
24,851 |
24,851 |
24,851 |
||
Tangible Assets |
1,543,842 |
2,254,476 |
3,968,746 |
3,986,959 |
3,871,498 |
3,794,014 |
||
Investments |
46,174 |
70,059 |
1,099,812 |
1,099,812 |
1,099,812 |
1,099,812 |
||
Current Assets |
|
|
327,841 |
652,871 |
1,168,382 |
1,931,010 |
2,559,155 |
3,175,721 |
Stocks |
126,353 |
266,451 |
305,075 |
530,404 |
479,822 |
458,546 |
||
Debtors |
74,757 |
83,836 |
104,545 |
252,237 |
230,619 |
221,525 |
||
Cash* |
124,022 |
288,186 |
751,563 |
1,099,092 |
1,799,439 |
2,446,373 |
||
Other |
2,709 |
14,398 |
7,199 |
49,276 |
49,276 |
49,276 |
||
Current Liabilities |
|
|
(248,420) |
(354,931) |
(661,171) |
(801,905) |
(698,496) |
(683,580) |
Creditors |
(224,386) |
(312,427) |
(612,862) |
(753,596) |
(650,187) |
(635,271) |
||
Short term borrowings |
(24,034) |
(42,504) |
(48,309) |
(48,309) |
(48,309) |
(48,309) |
||
Long Term Liabilities |
|
|
(729,290) |
(963,736) |
(1,647,799) |
(1,647,799) |
(1,647,799) |
(1,647,799) |
Long term borrowings |
(618,595) |
(770,902) |
(1,026,337) |
(1,026,337) |
(1,026,337) |
(1,026,337) |
||
Other long term liabilities |
(110,695) |
(192,834) |
(621,462) |
(621,462) |
(621,462) |
(621,462) |
||
Net Assets |
|
|
944,333 |
1,664,237 |
3,952,821 |
4,592,927 |
5,209,020 |
5,763,019 |
CASH FLOW |
||||||||
Operating Cash Flow |
|
|
394,984 |
628,617 |
1,046,370 |
1,143,850 |
1,386,081 |
1,365,879 |
Net Interest |
(26,734) |
(35,413) |
(53,774) |
(28,502) |
244 |
7,248 |
||
Tax |
(36,140) |
(109,494) |
(186,332) |
(223,048) |
(178,048) |
(168,831) |
||
Capex |
(689,469) |
(401,227) |
(335,599) |
(568,463) |
(371,828) |
(352,667) |
||
Acquisitions/disposals |
33,179 |
3,654 |
(19,000) |
20,000 |
40,000 |
0 |
||
Financing |
(7,820) |
2,402 |
100,000 |
151,000 |
0 |
0 |
||
Dividends |
(1,956) |
(6,154) |
(88,288) |
(147,307) |
(176,104) |
(204,695) |
||
Net Cash Flow |
(333,956) |
82,385 |
463,377 |
347,529 |
700,347 |
646,935 |
||
Opening net debt/(cash)* |
|
|
218,140 |
518,607 |
525,220 |
323,083 |
(24,446) |
(724,793) |
HP finance leases initiated |
0 |
0 |
0 |
0 |
0 |
0 |
||
Other |
33,489 |
(88,998) |
(261,240) |
0 |
0 |
0 |
||
Closing net debt/(cash)* |
|
|
518,607 |
525,220 |
323,083 |
(24,447) |
(724,793) |
(1,371,727) |
Source: Company sources, Edison Investment Research. Note: Presented on pro forma basis including SEMAFO from FY18 balance sheet and Teranga from FY20 balance sheet. EPS normalised from FY18 to reflect continuing business only. *Excludes restricted cash.
|
|
Research: Healthcare
Yesterday, Ergomed held its annual general meeting (AGM) and provided a high-level year to date trading update (four months to end-April 2021). The company guides to FY21e revenues in line with market expectations (Edison £119.6m; consensus £120.0m). Strong revenue growth has continued in its PrimeVigilance division, in line with prior trends (in FY20 revenues grew by 30%), and its CRO business has seen a further acceleration of growth from H220 (H220 service fee revenues up 13.5% vs H120). This indicates a continued rebound after a tough H120 for the CRO industry due to widespread lockdowns. The most pertinent takeaway is that adjusted EBITDA is now expected to be ‘materially ahead of market expectations’ in FY21 (Edison £21.7m; consensus £21.9m) due to effective cost management and the Ashfield and MedSource acquisition synergies being realised sooner than expected. We maintain our estimates and valuation of Ergomed (£683m or 1,400p/share) ahead of the more detailed H121 trading update due in July, but note upside potential to our estimates and possible consensus earnings upgrades.